New Hampshire legislation · 2026 Regular Session
New Hampshire SB465: classifying xylazine as a schedule III controlled drug.
Status: Failed, April 23, 2026
What the bill says
An act classifying xylazine as a schedule III controlled drug. Sen. Abbas, Dist 22; Sen. Birdsell, Dist 19; Sen. Carson, Dist 14; Sen. Rochefort, Dist 1; Sen. McConkey, Dist 3; Rep. L. Walsh, Rock. 15; Rep. Vose, Rock. 5; Rep. Roy, Rock. 31; Rep. Rhodes, Ches. 17 COMMITTEE: Judiciary ───────────────────────────────────────────────────────────────── ANALYSIS This bill classifies xylazine as a schedule III controlled drug. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Explanation: Matter added.
From the amended text, March 5, 2026:
AN ACT classifying xylazine as a schedule III controlled drug. Sen. Abbas, Dist 22; Sen. Birdsell, Dist 19; Sen. Carson, Dist 14; Sen. Rochefort, Dist 1; Sen. McConkey, Dist 3; Rep. L. Walsh, Rock. 15; Rep. Vose, Rock. 5; Rep. Roy, Rock. 31; Rep. Rhodes, Ches. 17 COMMITTEE: Judiciary ───────────────────────────────────────────────────────────────── ANALYSIS This bill classifies xylazine as a schedule III controlled drug. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Explanation: Matter added to current law appears in bold italics. Matter removed from current law appears [in brackets and struckthrough.] Matter which is either (a) all new or (b) repealed and reenacted appears in regular type. 03/05/2026 0842s 26-2002 09/05 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT classifying xylazine as a schedule III controlled drug. 318-B:1-d Xylazine. I. Notwithstanding the provisions of RSA 318-B:1-a, relative to scheduling by rulemaking of the commissioner of the department of …
Sponsors
- William Gannon (R, 23) · primary sponsor
- Daryl Abbas (R, 22)